tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CELC Stock Latest News

Celcuity’s Geda Triplet Therapy Shows Promising Phase III Results, Justifying Buy Rating
RatingsCelcuity’s Geda Triplet Therapy Shows Promising Phase III Results, Justifying Buy Rating
1d ago
CELC
Celcuity’s Strong Prospects: Buy Rating Affirmed Amidst Positive Drug Developments and Robust Financial Position
PremiumRatings
Celcuity’s Strong Prospects: Buy Rating Affirmed Amidst Positive Drug Developments and Robust Financial Position
1d ago
CELC
Celcuity Inc. Reports Promising Q2 2025 Results
PremiumCompany Announcements
Celcuity Inc. Reports Promising Q2 2025 Results
2d ago
CELC
Celcuity reports Q2 EPS (93c), consensus (85c)
PremiumThe Fly
Celcuity reports Q2 EPS (93c), consensus (85c)
2d ago
CELC
Celcuity’s Promising Clinical Trial Results and Strong Buy Recommendation by Andrew Berens
PremiumRatings
Celcuity’s Promising Clinical Trial Results and Strong Buy Recommendation by Andrew Berens
12d ago
CELC
Celcuity Completes $201.25 Million Convertible Notes Issuance
PremiumCompany AnnouncementsCelcuity Completes $201.25 Million Convertible Notes Issuance
15d ago
8K
CELC
Celcuity Raises $248.7 Million Through Stock and Notes
Premium
Company Announcements
Celcuity Raises $248.7 Million Through Stock and Notes
16d ago
8K
CELC
Celcuity 1.837M share Secondary priced at $38.00
Premium
The Fly
Celcuity 1.837M share Secondary priced at $38.00
17d ago
CELC
Celcuity Amends Loan Agreement and Launches Offerings
PremiumCompany Announcements
Celcuity Amends Loan Agreement and Launches Offerings
18d ago
8K
CELC
Why Is Celcuity Stock (CELC) Up 210% Today?
PremiumMarket News
Why Is Celcuity Stock (CELC) Up 210% Today?
19d ago
CELC
Celcuity price target raised to $60 from $28 at Leerink
PremiumThe Fly
Celcuity price target raised to $60 from $28 at Leerink
19d ago
CELC
Celcuity price target raised to $50 from $27 at H.C. Wainwright
PremiumThe Fly
Celcuity price target raised to $50 from $27 at H.C. Wainwright
19d ago
CELC
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Monday’s Biggest Stock Market Stories!
19d ago
DIS
NKE
Celcuity price target raised to $74 from $29 at Needham
Premium
The Fly
Celcuity price target raised to $74 from $29 at Needham
19d ago
CELC
U.S. strikes EU trade deal, Samsung to make AI6 chips for Tesla: Morning Buzz
Premium
The Fly
U.S. strikes EU trade deal, Samsung to make AI6 chips for Tesla: Morning Buzz
19d ago
C
BA
Relay Therapeutics has positive read from Celcuity data, says Barclays
PremiumThe Fly
Relay Therapeutics has positive read from Celcuity data, says Barclays
19d ago
CELC
RLAY
Stifel expects Celcuity shares to move ‘meaningfully higher’ after data
PremiumThe Fly
Stifel expects Celcuity shares to move ‘meaningfully higher’ after data
19d ago
CELC
Celcuity Announces Positive Phase 3 Trial Results
PremiumCompany Announcements
Celcuity Announces Positive Phase 3 Trial Results
19d ago
8K
CELC
Positive VIKTORIA-1 Trial Results and Favorable Safety Profile Drive Buy Rating for Geda in Metastatic Breast Cancer
PremiumRatings
Positive VIKTORIA-1 Trial Results and Favorable Safety Profile Drive Buy Rating for Geda in Metastatic Breast Cancer
19d ago
CELC
Celcuity report statistically significant results from Phase 3 VIKTORIA-1 trial
PremiumThe FlyCelcuity report statistically significant results from Phase 3 VIKTORIA-1 trial
19d ago
CELC
Celcuity doses first patient in VIKTORIA-2 trial
Premium
The Fly
Celcuity doses first patient in VIKTORIA-2 trial
23d ago
CELC
Celcuity announces issuance of new patent for gedatolisib
Premium
The Fly
Celcuity announces issuance of new patent for gedatolisib
1M ago
CELC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >